Literature DB >> 10516225

Differential NF-kappaB activation after intratracheal endotoxin.

T S Blackwell1, L H Lancaster, T R Blackwell, A Venkatakrishnan, J W Christman.   

Abstract

We examined the relationship between nuclear factor (NF)-kappaB DNA binding activity, cytokine gene expression, and neutrophilic alveolitis in rats after intratracheal (IT) instillation of endotoxin [lipopolysaccharide (LPS)]. NF-kappaB activation in lung tissue mirrored neutrophilic alveolitis after IT LPS instillation, with NF-kappaB activation and neutrophilic influx beginning 2 h after IT LPS doses of 0.01 mg/kg or greater. In lung lavage fluid cells, however, transient NF-kappaB activation was present in alveolar macrophages by 15 min after IT LPS instillation, followed by a second peak of NF-kappaB activation corresponding to the onset on neutrophilic alveolitis. For cytokines thought to be NF-kappaB dependent, two different patterns of mRNA expression were found. Interleukin (IL)-1alpha, IL-1beta, and tumor necrosis factor-alpha showed increased mRNA by 30 min after IT LPS instillation, but IL-6- and cytokine-induced neutrophil chemoattractant mRNAs were not substantially increased until 2 h after IT LPS instillation. Therefore, IT LPS causes differential NF-kappaB activation in air space cells and lung tissue, which likely determines production of key cytokines and directs the evolution of neutrophilic alveolitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516225     DOI: 10.1152/ajplung.1999.277.4.L823

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia.

Authors:  Matthew R Jones; Benjamin T Simms; Michal M Lupa; Mariya S Kogan; Joseph P Mizgerd
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

2.  NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy.

Authors:  Ramon C J Langen; Astrid Haegens; Juanita H J Vernooy; Emiel F M Wouters; Menno P J de Winther; Harald Carlsen; Chad Steele; Steven E Shoelson; Annemie M W J Schols
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-26       Impact factor: 6.914

3.  Activation of type II alveolar epithelial cells during acute endotoxemia.

Authors:  Vasanthi R Sunil; Agnieszka J Connor; Yan Guo; Jeffrey D Laskin; Debra L Laskin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

4.  Comparison of in vivo bioluminescence imaging and lavage biomarkers to assess pulmonary inflammation.

Authors:  Suzana Hadina; Christine L Wohlford-Lenane; Peter S Thorne
Journal:  Toxicology       Date:  2011-11-23       Impact factor: 4.221

5.  Acute inflammation induces insulin-like growth factor-1 to mediate Bcl-2 and Muc5ac expression in airway epithelial cells.

Authors:  Hitendra S Chand; Zekarias Woldegiorgis; Kurt Schwalm; Jake McDonald; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2012-08-09       Impact factor: 6.914

6.  Molecular imaging of folate receptor β-positive macrophages during acute lung inflammation.

Authors:  Wei Han; Rinat Zaynagetdinov; Fiona E Yull; Vasiliy V Polosukhin; Linda A Gleaves; Harikrishna Tanjore; Lisa R Young; Todd E Peterson; H Charles Manning; Lawrence S Prince; Timothy S Blackwell
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

7.  Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.

Authors:  Lynnelle A Pittet; Lee J Quinton; Kazuko Yamamoto; Bryanne E Robson; J Daniel Ferrari; Hana Algül; Roland M Schmid; Joseph P Mizgerd
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

8.  Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia.

Authors:  Kazuko Yamamoto; Joseph D Ferrari; Yuxia Cao; Maria I Ramirez; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  Myeloid cells control termination of lung inflammation through the NF-kappaB pathway.

Authors:  Wei Han; Myungsoo Joo; M Brett Everhart; John W Christman; Fiona E Yull; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-19       Impact factor: 5.464

10.  p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide Treatment.

Authors:  Jamie A Saxon; Dong-Sheng Cheng; Wei Han; Vasiliy V Polosukhin; Allyson G McLoed; Bradley W Richmond; Linda A Gleaves; Harikrishna Tanjore; Taylor P Sherrill; Whitney Barham; Fiona E Yull; Timothy S Blackwell
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.